Grantham, Mayo, Van Otterloo & Co (GMO)
OPTR

Grantham, Mayo, Van Otterloo & Co (GMO)’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-207,000
Closed -$2.61M – 731
2013
Q3 		$2.61M Buy
+207,000
New +$2.74M 0.01% 383

Grantham, Mayo, Van Otterloo & Co (GMO)'s OPTR Position: Q4 2013 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 207,000 shares — an estimated $2.61M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $2.61M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 207,000 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $2.61M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $2.61M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2013, filed 13 Feb 2014.